Search for a trial | Research with human participants

1 results

An International Prospective Open-label, Randomized, Phase III Study comparing 177Lu-PSMA-617 in combination with Standard of Care, versus Standard of Care alone, in adult male patients with Metastatic Hormone Sensitive Prostate Cancer (mHSPC)

Approved WMORecruiting

This study has been transitioned to CTIS with ID 2023-507970-42-00 check the CTIS register for the current data. The purpose of this study is to evaluate the efficacy and safety of 177Lu-PSMA-617 in combination with Standard of Care, versus Standard…